Christopher King, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    United Therapeutics
    Topic:
    pah
    Date added:
    04/06/2023
    Date updated:
    02/02/2024
    Relationship end date:
    02/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Merck
    Topic:
    pah
    Date added:
    04/06/2023
    Date updated:
    02/02/2024
    Relationship end date:
    02/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Altavant
    Topic:
    pah
    Date added:
    04/06/2023
    Date updated:
    02/02/2024
    Relationship end date:
    02/02/2024
Return to 2024 ISHV Cath, Heart and Lung Conferences: Pulmonary Hypertension